Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition.
Vimentin is used widely as a marker of the epithelial to mesenchymal transitions (EMTs) that take place during embryogenesis and metastasis, yet the functional implications of the expression of this type III intermediate filament (IF) protein are poorly understood. Using form factor analysis and quantitative Western blotting of normal, metastatic, and vimentin-null cell lines, we show that the level of expression of vimentin IFs (VIFs) correlates with mesenchymal cell shape and motile behavior. The reorganization of VIFs caused by expressing a dominant-negative mutant or by silencing vimentin with shRNA (neither of which alter microtubule or microfilament assembly) causes mesenchymal cells to adopt epithelial shapes. Following the microinjection of vimentin or transfection with vimentin cDNA, epithelial cells rapidly adopt mesenchymal shapes coincident with VIF assembly. These shape transitions are accompanied by a loss of desmosomal contacts, an increase in cell motility, and a significant increase in focal adhesion dynamics. Our results demonstrate that VIFs play a predominant role in the changes in shape, adhesion, and motility that occur during the EMT.
Mendez
Melissa G
MG
Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Kojima
Shin-Ichiro
S
Goldman
Robert D
RD
D001943:Breast Neoplasms / Q000473:pathology; D002448:Cell Adhesion / Q000502:physiology*; D002465:Cell Movement / Q000502:physiology*; D048430:Cell Shape; D054338:Cell Transdifferentiation; D003896:Desmosomes; D004847:Epithelial Cells / Q000166:cytology*; D005260:Female; D006801:Humans; D008648:Mesoderm / Q000166:cytology; D034741:RNA, Small Interfering / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D014746:Vimentin / Q000502:physiology*
D034741:RNA, Small Interfering; D014746:Vimentin